Sean Krohn, PharmD, CSP, MSCS

home / authors / sean-krohn-pharmd-csp-mscs

Articles

Cardiovascular disease doctor or cardiologist holding red heart in clinic or hospital exam room office for csr professional medical service, cardiology health care and world heart health day concept - Image credit: Chinnapong | stock.adobe.com

Advancing Pericarditis Care: The Evolving Role of IL-1 Inhibition and Pharmacist-Cardiologist Collaboration

Kennedy Ferruggia, Assistant Editor;Luke Halpern, Assistant Editor;Allan L. Klein, MD, FRCP (C), FACC, FAHA, FASE, FESC;Sean Krohn, PharmD, CSP, MSCS
July 7th 2025

Experts discussed the promising future of pericarditis treatment.

Read More

Inflammation concept, inflammated human tissues 3d rendering - Image credit: picture-waterfall | stock.adobe.com

Navigating Rilonacept Therapy: Dose Adjustments, Discontinuation, and Patient Support Strategies

Kennedy Ferruggia, Assistant Editor;Luke Halpern, Assistant Editor;Allan L. Klein, MD, FRCP (C), FACC, FAHA, FASE, FESC;Sean Krohn, PharmD, CSP, MSCS
July 1st 2025

Pharmacists and clinicians collaborate to carefully manage rilonacept therapy.

Read More

Tired scared retiree man holding chest with anginal symptoms, pallor and diaphoresis at home. Suffering male with cardiac origin pain, prexcordial pressure, arrhythmia risk, urgent medical attention - Image credit: DimaBerlin | stock.adobe.com

Collaborative Management of Severe Pericarditis: The Role of Pharmacists in Rilonacept Treatment

Kennedy Ferruggia, Assistant Editor;Luke Halpern, Assistant Editor;Allan L. Klein, MD, FRCP (C), FACC, FAHA, FASE, FESC;Sean Krohn, PharmD, CSP, MSCS
June 11th 2025

Pharmacists play a critical role in managing complex pericarditis cases.

Read More

Image credit: Sebastian Kaulitzki | stock.adobe.com

Rilonacept in Recurrent Pericarditis: Mechanism of Action, Patient Management, and Clinical Considerations

Kennedy Ferruggia, Assistant Editor;Luke Halpern, Assistant Editor;Allan L. Klein, MD, FRCP (C), FACC, FAHA, FASE, FESC;Sean Krohn, PharmD, CSP, MSCS
June 6th 2025

Rilonacept offers a targeted approach to treating recurrent pericarditis by blocking IL-1 inflammatory pathways.

Read More

Latest Updated Articles

raw vegetables with blood glucose meter, syringe, lancet and stethoscope on desk, diabetes healthy diet concept - Image credit: neirfy | stock.adobe.com
Published: June 12th 2025 | Updated: June 16th 2025
Study: How Individual Carbohydrate Responses Reveal Metabolic Health and Potential Biomarkers
Milan, Italy - APRIL 10, 2021: CDC logo on laptop screen seen through an optical prism. Illustrative editorial image from CDC website.
Published: June 10th 2025 | Updated: June 12th 2025
Department of Health and Human Services Reconstitutes ACIP, Removing 17 Sitting Members
NLA 2025: Managing Omega-3 Therapy With Statins, PCSK9 Inhibitors for Cardiovascular Care
Published: June 2nd 2025 | Updated: June 11th 2025
NLA 2025: Managing Omega-3 Therapy With Statins, PCSK9 Inhibitors for Cardiovascular Care
Image credit: catalin | stock.adobe.com
Published: June 3rd 2025 | Updated: June 11th 2025
ASCO 2025: Zongertinib Shows Strong Potential in HER2-Mutant NSCLC Treatment Landscape
Emerging Data: Impacts of ROCKstar and AGAVE-201
Published: May 30th 2025 | Updated: June 5th 2025
Emerging Data: Impacts of ROCKstar and AGAVE-201
Mother holding baby's foot with measles spots | Image Credit: © rostock-studio - stock.adobe.com
Published: April 18th 2025 | Updated: April 21st 2025
Measles Cases Climb to 800 in United States as Outbreak Spreads Across Borders
© 2025 MJH Life Sciences

All rights reserved.